Prevalence and Variation of Developmental Screening and Surveillance in Early Childhood

Ashley H. Hirai, Michael D. Kogan, Veni Kandasamy, Colleen Reuland, Christina Bethell

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

IMPORTANCE Since 2001, the American Academy of Pediatrics has recommended universal developmental screening and surveillance to promote early diagnosis and intervention and to improve the outcomes of children with developmental delays and disabilities. OBJECTIVE To examine the current prevalence and variation of developmental screening and surveillance of children by various sociodemographic, enabling, and health characteristics. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional analysis of the Health Resources and Services Administration's 2016 National Survey of Children's Health-a nationally representative survey of US children completed between June 2016 and February 2017-examined 5668 randomly selected children 9 through 35 months of age whose parent or caregiver responded to the address-based survey by mail or via a website. All analyses were weighted to account for the probability of selection and nonresponse and to reflect population counts of all noninstitutionalized US children residing in housing units. MAIN OUTCOMES AND MEASURES Developmental screening was measured through a validated set of 3 items indicating receipt in the past year of parent-completed screening from a health care professional with age-appropriate content regarding language development and social behavior. Surveillance was determined by an item capturing verbal elicitation of developmental concerns by a health care professional. RESULTS Of the estimated 9.0 million children aged 9 through 35 months, an estimated 30.4% (95% CI, 28.0%-33.0%) were reported by their parent or guardian to have received a parent-completed developmental screening and 37.1% (95% CI, 34.4%-39.8%) were reported to have received developmental surveillance from a health care professional in the past year. Characteristics associated with screening and/or surveillance that remained significant after adjustment included primary household language, family structure, household education, income, medical home, past-year preventive visit, child health status, and special health care needs. Having health care that meets medical home criteria was significantly associated with both developmental screening (adjusted rate ratio, 1.34; 95% CI, 1.13-1.57) and surveillance (adjusted rate ratio, 1.24; 95% CI, 1.08-1.42), representing an 8 to 9 absolute percentage point increase. State-level differences spanned 40 percentage points for screening (17.2% in Mississippi and 58.8% in Oregon) and surveillance (19.1% in Mississippi and 60.8% in Oregon), with approximately 90% of variation not explained by child and family characteristics. CONCLUSIONS AND RELEVANCE Despite more than a decade of initiatives, rates of developmental screening and surveillance remain low. However, state-level variation indicates continued potential for improvement. Systems-level quality improvement efforts, building on the medical home, will be necessary to achieve recommended screening and surveillance goals.

Original languageEnglish (US)
Pages (from-to)857-866
Number of pages10
JournalJAMA Pediatrics
Volume172
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Patient-Centered Care
Delivery of Health Care
Mississippi
United States Health Resources and Services Administration
Social Adjustment
Developmental Disabilities
Language Development
Social Behavior
Postal Service
Quality Improvement
Caregivers
Health Status
Early Diagnosis
Language
Cross-Sectional Studies
Pediatrics
Education
Health
Population
Surveys and Questionnaires

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Prevalence and Variation of Developmental Screening and Surveillance in Early Childhood. / Hirai, Ashley H.; Kogan, Michael D.; Kandasamy, Veni; Reuland, Colleen; Bethell, Christina.

In: JAMA Pediatrics, Vol. 172, No. 9, 01.09.2018, p. 857-866.

Research output: Contribution to journalArticle

Hirai, AH, Kogan, MD, Kandasamy, V, Reuland, C & Bethell, C 2018, 'Prevalence and Variation of Developmental Screening and Surveillance in Early Childhood', JAMA Pediatrics, vol. 172, no. 9, pp. 857-866. https://doi.org/10.1001/jamapediatrics.2018.1524
Hirai, Ashley H. ; Kogan, Michael D. ; Kandasamy, Veni ; Reuland, Colleen ; Bethell, Christina. / Prevalence and Variation of Developmental Screening and Surveillance in Early Childhood. In: JAMA Pediatrics. 2018 ; Vol. 172, No. 9. pp. 857-866.
@article{e447295bd4d948d4841f362fee4f8beb,
title = "Prevalence and Variation of Developmental Screening and Surveillance in Early Childhood",
abstract = "IMPORTANCE Since 2001, the American Academy of Pediatrics has recommended universal developmental screening and surveillance to promote early diagnosis and intervention and to improve the outcomes of children with developmental delays and disabilities. OBJECTIVE To examine the current prevalence and variation of developmental screening and surveillance of children by various sociodemographic, enabling, and health characteristics. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional analysis of the Health Resources and Services Administration's 2016 National Survey of Children's Health-a nationally representative survey of US children completed between June 2016 and February 2017-examined 5668 randomly selected children 9 through 35 months of age whose parent or caregiver responded to the address-based survey by mail or via a website. All analyses were weighted to account for the probability of selection and nonresponse and to reflect population counts of all noninstitutionalized US children residing in housing units. MAIN OUTCOMES AND MEASURES Developmental screening was measured through a validated set of 3 items indicating receipt in the past year of parent-completed screening from a health care professional with age-appropriate content regarding language development and social behavior. Surveillance was determined by an item capturing verbal elicitation of developmental concerns by a health care professional. RESULTS Of the estimated 9.0 million children aged 9 through 35 months, an estimated 30.4{\%} (95{\%} CI, 28.0{\%}-33.0{\%}) were reported by their parent or guardian to have received a parent-completed developmental screening and 37.1{\%} (95{\%} CI, 34.4{\%}-39.8{\%}) were reported to have received developmental surveillance from a health care professional in the past year. Characteristics associated with screening and/or surveillance that remained significant after adjustment included primary household language, family structure, household education, income, medical home, past-year preventive visit, child health status, and special health care needs. Having health care that meets medical home criteria was significantly associated with both developmental screening (adjusted rate ratio, 1.34; 95{\%} CI, 1.13-1.57) and surveillance (adjusted rate ratio, 1.24; 95{\%} CI, 1.08-1.42), representing an 8 to 9 absolute percentage point increase. State-level differences spanned 40 percentage points for screening (17.2{\%} in Mississippi and 58.8{\%} in Oregon) and surveillance (19.1{\%} in Mississippi and 60.8{\%} in Oregon), with approximately 90{\%} of variation not explained by child and family characteristics. CONCLUSIONS AND RELEVANCE Despite more than a decade of initiatives, rates of developmental screening and surveillance remain low. However, state-level variation indicates continued potential for improvement. Systems-level quality improvement efforts, building on the medical home, will be necessary to achieve recommended screening and surveillance goals.",
author = "Hirai, {Ashley H.} and Kogan, {Michael D.} and Veni Kandasamy and Colleen Reuland and Christina Bethell",
year = "2018",
month = "9",
day = "1",
doi = "10.1001/jamapediatrics.2018.1524",
language = "English (US)",
volume = "172",
pages = "857--866",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Prevalence and Variation of Developmental Screening and Surveillance in Early Childhood

AU - Hirai, Ashley H.

AU - Kogan, Michael D.

AU - Kandasamy, Veni

AU - Reuland, Colleen

AU - Bethell, Christina

PY - 2018/9/1

Y1 - 2018/9/1

N2 - IMPORTANCE Since 2001, the American Academy of Pediatrics has recommended universal developmental screening and surveillance to promote early diagnosis and intervention and to improve the outcomes of children with developmental delays and disabilities. OBJECTIVE To examine the current prevalence and variation of developmental screening and surveillance of children by various sociodemographic, enabling, and health characteristics. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional analysis of the Health Resources and Services Administration's 2016 National Survey of Children's Health-a nationally representative survey of US children completed between June 2016 and February 2017-examined 5668 randomly selected children 9 through 35 months of age whose parent or caregiver responded to the address-based survey by mail or via a website. All analyses were weighted to account for the probability of selection and nonresponse and to reflect population counts of all noninstitutionalized US children residing in housing units. MAIN OUTCOMES AND MEASURES Developmental screening was measured through a validated set of 3 items indicating receipt in the past year of parent-completed screening from a health care professional with age-appropriate content regarding language development and social behavior. Surveillance was determined by an item capturing verbal elicitation of developmental concerns by a health care professional. RESULTS Of the estimated 9.0 million children aged 9 through 35 months, an estimated 30.4% (95% CI, 28.0%-33.0%) were reported by their parent or guardian to have received a parent-completed developmental screening and 37.1% (95% CI, 34.4%-39.8%) were reported to have received developmental surveillance from a health care professional in the past year. Characteristics associated with screening and/or surveillance that remained significant after adjustment included primary household language, family structure, household education, income, medical home, past-year preventive visit, child health status, and special health care needs. Having health care that meets medical home criteria was significantly associated with both developmental screening (adjusted rate ratio, 1.34; 95% CI, 1.13-1.57) and surveillance (adjusted rate ratio, 1.24; 95% CI, 1.08-1.42), representing an 8 to 9 absolute percentage point increase. State-level differences spanned 40 percentage points for screening (17.2% in Mississippi and 58.8% in Oregon) and surveillance (19.1% in Mississippi and 60.8% in Oregon), with approximately 90% of variation not explained by child and family characteristics. CONCLUSIONS AND RELEVANCE Despite more than a decade of initiatives, rates of developmental screening and surveillance remain low. However, state-level variation indicates continued potential for improvement. Systems-level quality improvement efforts, building on the medical home, will be necessary to achieve recommended screening and surveillance goals.

AB - IMPORTANCE Since 2001, the American Academy of Pediatrics has recommended universal developmental screening and surveillance to promote early diagnosis and intervention and to improve the outcomes of children with developmental delays and disabilities. OBJECTIVE To examine the current prevalence and variation of developmental screening and surveillance of children by various sociodemographic, enabling, and health characteristics. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional analysis of the Health Resources and Services Administration's 2016 National Survey of Children's Health-a nationally representative survey of US children completed between June 2016 and February 2017-examined 5668 randomly selected children 9 through 35 months of age whose parent or caregiver responded to the address-based survey by mail or via a website. All analyses were weighted to account for the probability of selection and nonresponse and to reflect population counts of all noninstitutionalized US children residing in housing units. MAIN OUTCOMES AND MEASURES Developmental screening was measured through a validated set of 3 items indicating receipt in the past year of parent-completed screening from a health care professional with age-appropriate content regarding language development and social behavior. Surveillance was determined by an item capturing verbal elicitation of developmental concerns by a health care professional. RESULTS Of the estimated 9.0 million children aged 9 through 35 months, an estimated 30.4% (95% CI, 28.0%-33.0%) were reported by their parent or guardian to have received a parent-completed developmental screening and 37.1% (95% CI, 34.4%-39.8%) were reported to have received developmental surveillance from a health care professional in the past year. Characteristics associated with screening and/or surveillance that remained significant after adjustment included primary household language, family structure, household education, income, medical home, past-year preventive visit, child health status, and special health care needs. Having health care that meets medical home criteria was significantly associated with both developmental screening (adjusted rate ratio, 1.34; 95% CI, 1.13-1.57) and surveillance (adjusted rate ratio, 1.24; 95% CI, 1.08-1.42), representing an 8 to 9 absolute percentage point increase. State-level differences spanned 40 percentage points for screening (17.2% in Mississippi and 58.8% in Oregon) and surveillance (19.1% in Mississippi and 60.8% in Oregon), with approximately 90% of variation not explained by child and family characteristics. CONCLUSIONS AND RELEVANCE Despite more than a decade of initiatives, rates of developmental screening and surveillance remain low. However, state-level variation indicates continued potential for improvement. Systems-level quality improvement efforts, building on the medical home, will be necessary to achieve recommended screening and surveillance goals.

UR - http://www.scopus.com/inward/record.url?scp=85053001806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053001806&partnerID=8YFLogxK

U2 - 10.1001/jamapediatrics.2018.1524

DO - 10.1001/jamapediatrics.2018.1524

M3 - Article

AN - SCOPUS:85053001806

VL - 172

SP - 857

EP - 866

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 9

ER -